Independent reference site — Not affiliated with the U.S. Food and Drug Administration. All data sourced from public FDA databases.
Live · Refreshed every 6 hours

Diabetes drug recalls

Every Class I, II, and III FDA recall affecting diabetes medications. Drugs in this category include Metformin, Insulin Glargine, Sitagliptin.

Verified from FDA on Refreshes every 6 hoursFDA-Sourced

February 6, 20191 recall

July 25, 20181 recall

June 27, 20181 recall

December 20, 20171 recall

April 5, 20175 recalls

RecallClassStatus
Atorvastatin Calcium Tablets, 40 mg*, packaged in a) 90-count bottles (NDC 0378-3952-09) and b) 500-count bottles (NDC 0378-3952-07); Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with… · Mylan Pharmaceuticals Inc. · 444,201 bottlesClass IITerminatedAtorvastatin Calcium Tablets, 20 mg*, packaged in a) 90-count bottles (NDC 0378-3951-09) and b) 500-count bottles (NDC 0378-3951-07); Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with… · Mylan Pharmaceuticals Inc. · 299,112 bottlesClass IITerminatedAtorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with… · Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · 1,527 cartonsClass IITerminatedAtorvastatin Calcium Tablets, 10 mg*, packaged in a) 90-count bottles (NDC 0378-3950-77); b) 90-count bottles (NDC 0378-3950-09); c) 500-count bottles (NDC 0378-3950-05); d) 500-count bottles (NDC 0378-3950-07), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with… · Mylan Pharmaceuticals Inc. · 1,233,107 bottlesClass IITerminatedAtorvastatin Calcium Tablets, 80 mg*, packaged in a) 90-count bottles (NDC 0378-3953-09) and b) 500-count bottles (NDC 0378-3953-07), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with… · Mylan Pharmaceuticals Inc. · 452,269 bottlesClass IITerminated

December 7, 20161 recall

How FDA classifies recalls

Class I: The drug may cause serious health consequences or death. Examples include the wrong drug in a bottle, a drug contaminated with bacteria, or a life-threatening allergen not declared on the label.

Class II: The drug may cause temporary or medically reversible adverse health consequences, or the probability of serious consequences is remote. Examples include a dissolution failure, a labeling error that affects dosing, or a nitrosamine impurity above the daily intake limit.

Class III: Use of the drug is unlikely to cause adverse health consequences, but the product violates FDA regulations. Examples include an incorrect tablet count per bottle, minor labeling issues, or packaging defects.

Definitions sourced from FDA Recall Classifications →

For information only. MedivaScan summarizes public FDA data and is not medical advice. Consult a healthcare professional before changing any medication. If you experience a serious reaction, contact your doctor or call 911.